Cell screening by ENUMERAL. The total number of cells/devices (single cell arrays) screened by ENUMERAL will be data driven and will be determined by ENUMERAL. Factors that will determine this number will include: · The number of cells available (for the plasma cell sample screening) · Target coverage, specificity and affinity The maximum number of devices that will be run by ENUMERAL for the antibody screening is estimated to be * (not including devices used in the assay development). ENUMERAL will attempt to screen all three cell types for each mouse (spleenocytes, lymph nodes, bone marrow) as outlined below given that SANOFI US supplies sufficient of all three cell types for each mouse. · Spleenocytes B cells: * · Lymph node cells: * · Bone marrow plasma cells: * Grand total = *
Appears in 3 contracts
Sources: Research Agreement (Enumeral Biomedical Holdings, Inc.), Research Agreement (Enumeral Biomedical Holdings, Inc.), Research Agreement (Enumeral Biomedical Holdings, Inc.)